Qsymia Development

Vanton designs Qsymia (called Qnexa in its early stage) formulation. It consists of an IR component and a SR component.

Vanton’s contribution include:

  • Characterizing API including API packaging and stability
  • Formulation design/consultation
  • Dosage form design and process (working with CMO)
  • Drug product stability and degradation mechanism modeling
  • Participate in NDA CMC section
  • Post-market support and product return
  • Design a second generation Qsymia (bilayer tablet)
qsymia logo

Vanton Labs can help you move your product development forward.

Copyright © 2015, Vanton Research Laboratory, LLC. All rights reserved.